NantCell
Developing knowledge by harnessing the power of the immune system to treat cancer.
Employees
Enterprise value
$120—180m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
N/A | Spinout | ||
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by NantCell
Edit
ACQUISITION by NantCell Jun 2017
ACQUISITION by NantCell Jan 2011
ACQUISITION by NantCell Jun 2015
ACQUISITION Feb 2020
ACQUISITION by Molex Dec 2021
ACQUISITION by NantCell Jul 2017
exited